MMP9 and colorectal carcinoma: Through an immunofluorescence method, we found that PTGS2 inhibition led to a clear downregulation in the expression of the metastasis-related protein MMP9 in both HCT116 and SW480 CRC cell lines (Fig. 2C), supporting the notion that PTGS2 silencing impairs cell migration and invasion in vitro.